Nurix Therapeutics Statistics
Total Valuation
NRIX has a market cap or net worth of $1.65 billion. The enterprise value is $1.19 billion.
Important Dates
The next estimated earnings date is Thursday, October 10, 2024, after market close.
| Earnings Date | Oct 10, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
NRIX has 64.41 million shares outstanding. The number of shares has increased by 6.22% in one year.
| Shares Outstanding | 64.41M |
| Shares Change (YoY) | +6.22% |
| Shares Change (QoQ) | +13.61% |
| Owned by Insiders (%) | 0.98% |
| Owned by Institutions (%) | 82.93% |
| Float | 50.88M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 22.76 |
| Forward PS | 24.70 |
| PB Ratio | 4.35 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 19.11 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.57, with a Debt / Equity ratio of 0.08.
| Current Ratio | 5.57 |
| Quick Ratio | 5.49 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -52.33% and return on invested capital (ROIC) is -33.48%.
| Return on Equity (ROE) | -52.33% |
| Return on Assets (ROA) | -25.98% |
| Return on Capital (ROIC) | -33.48% |
| Revenue Per Employee | $219,377 |
| Profits Per Employee | -$580,993 |
| Employee Count | 284 |
| Asset Turnover | 0.14 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NRIX has paid $180,000 in taxes.
| Income Tax | 180,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +166.97% in the last 52 weeks. The beta is 2.23, so NRIX's price volatility has been higher than the market average.
| Beta (5Y) | 2.23 |
| 52-Week Price Change | +166.97% |
| 50-Day Moving Average | 22.92 |
| 200-Day Moving Average | 15.55 |
| Relative Strength Index (RSI) | 57.28 |
| Average Volume (20 Days) | 489,121 |
Short Selling Information
The latest short interest is 9.26 million, so 14.38% of the outstanding shares have been sold short.
| Short Interest | 9.26M |
| Short Previous Month | 9.24M |
| Short % of Shares Out | 14.38% |
| Short % of Float | 18.20% |
| Short Ratio (days to cover) | 15.25 |
Income Statement
In the last 12 months, NRIX had revenue of $62.30 million and -$165.00 million in losses. Loss per share was -$2.92.
| Revenue | 62.30M |
| Gross Profit | -134.19M |
| Operating Income | -179.11M |
| Pretax Income | -164.82M |
| Net Income | -165.00M |
| EBITDA | -172.25M |
| EBIT | -179.11M |
| Loss Per Share | -$2.92 |
Full Income StatementBalance Sheet
The company has $443.14 million in cash and $28.82 million in debt, giving a net cash position of $423.70 million or $6.58 per share.
| Cash & Cash Equivalents | 443.14M |
| Total Debt | 28.82M |
| Net Cash | 423.70M |
| Net Cash Per Share | $6.58 |
| Equity (Book Value) | 370.69M |
| Book Value Per Share | 5.76 |
| Working Capital | 369.44M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$96.10 million and capital expenditures -$9.87 million, giving a free cash flow of -$105.97 million.
| Operating Cash Flow | -96.10M |
| Capital Expenditures | -9.87M |
| Free Cash Flow | -105.97M |
| FCF Per Share | -$1.65 |
Full Cash Flow StatementMargins
Gross margin is -215.39%, with operating and profit margins of -287.47% and -264.84%.
| Gross Margin | -215.39% |
| Operating Margin | -287.47% |
| Pretax Margin | -264.55% |
| Profit Margin | -264.84% |
| EBITDA Margin | -276.46% |
| EBIT Margin | -287.47% |
| FCF Margin | -170.08% |
Dividends & Yields
NRIX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -6.22% |
| Shareholder Yield | -6.22% |
| Earnings Yield | -10.22% |
| FCF Yield | -6.56% |
Analyst Forecast
The average price target for NRIX is $26.92, which is 5.07% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $26.92 |
| Price Target Difference | 5.07% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 31.17% |
| EPS Growth Forecast (5Y) | -10.43% |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
NRIX has an Altman Z-Score of 0.27 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.27 |
| Piotroski F-Score | 2 |